767351-91-7Relevant academic research and scientific papers
Structure-activity relationships of C-17-substituted estratriene-3-O- sulfamates as anticancer agents
Jourdan, Fabrice,Leese, Mathew P.,Dohle, Wolfgang,Ferrandis, Eric,Newman, Simon P.,Chander, Surinder,Purohit, Atul,Potter, Barry V. L.
experimental part, p. 4863 - 4879 (2011/09/20)
The synthesis and antiproliferative activities of analogues of 2-substituted estradiol-3,17-O,O-bis-sulfamates (E2bisMATEs) are discussed. Modifications of the C-17 substituent confirm that an H-bond acceptor is essential for high activity; its optimal linkage to C-17 and the local environment in which it resides are defined. In the non-sulfamoylated series 17β-acyl substitution delivers 48b, the most potent compound identified to date. In the sulfamate series a number of permutations of linker and H-bond acceptor deliver excellent activity, with 55, 61, 65, 49a, and 49b proving especially promising. The in vivo potential of these compounds was explored in the NCI hollow fiber assay and also in a mouse Matrigel model of antiangiogenesis in which 49 and 55 show significant inhibitory activity.
OESTROGEN DERIVATIVES AS INHIBITORS OF STEROID SULPHATASE
-
Page 122-123, (2010/02/08)
The present invention provides a compound comprising a steroidal ring system and an optional group R1 selected from any one of -OH, a sulphamate group, a phosphonate group, a thiophosphonate group, a sulphonate group or a sulphonamide group; wh
